⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for t lymphocytes

Every month we try and update this database with for t lymphocytes cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCLNCT03602157
Lymphoma
Immune System D...
Immunoprolifera...
Lymphatic Disea...
Lymphoprolifera...
Neoplasms
Cutaneous Lymph...
Cutaneous Anapl...
Mycosis Fungoid...
Sezary Syndrome
Lymphomatoid Pa...
Cutaneous T Cel...
Gray Zone Lymph...
ATLCAR.CD30.CCR...
ALTCAR.CD30 cel...
Bendamustine
Fludarabine
18 Years - UNC Lineberger Comprehensive Cancer Center
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T CellsNCT00562666
Hepatocellular ...
T gamma delta l...
18 Years - Rennes University Hospital
Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T LymphocytesNCT00953420
Nasopharyngeal ...
Docetaxel
Carboplatin
Dexamethasone
EBV-specific cy...
G-CSF or Peg-GC...
10 Years - Baylor College of Medicine
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHLNCT02690545
Lymphoma
Lymphoma, Non-H...
Immune System D...
Immunoprolifera...
Lymphatic Disea...
Lymphoprolifera...
Neoplasms
Neoplasms by Hi...
ATLCAR.CD30 cel...
3 Years - UNC Lineberger Comprehensive Cancer Center
Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma PatientsNCT01336270
Melanoma
biological coll...
18 Years - Assistance Publique - Hôpitaux de Paris
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALLNCT03016377
Acute Lymphobla...
Immune System D...
Immunoprolifera...
iC9-CAR19 cells
Rimiducid
Cyclophosphamid...
Fludarabine
3 Years - 70 YearsUNC Lineberger Comprehensive Cancer Center
Administration of T Lymphocytes for Prevention of Relapse of LymphomasNCT02663297
Hodgkin Disease
Lymphoma
Lymphoma, Non-H...
Immune System D...
Immunoprolifera...
Lymphatic Disea...
Lymphoprolifera...
Neoplasms
Neoplasms by Hi...
ATLCAR.CD30 cel...
3 Years - UNC Lineberger Comprehensive Cancer Center
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.NCT04223765
Mantle Cell Lym...
Follicular Lymp...
Splenic Margina...
Extranodal Marg...
Nodal Marginal ...
Indolent Non-ho...
CAR.k.28
Fludarabine
Cyclophosphamid...
Bendamustine
18 Years - UNC Lineberger Comprehensive Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: